Nexsen Limited (ASX:NXN)
Australia · Delayed Price · Currency is AUD 0.2400
+0.0050 (2.13%)
Last updated: Jul 31, 2026, 11:51 AM AEST
Nexsen Market Cap
Nexsen has a market cap or net worth of 48.05 million as of July 31, 2026.
Market Cap
48.05M
Enterprise Value
41.17M
Revenue
931.61K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.24
ChartMarket Cap Chart
Since October 14, 2025, Nexsen's market cap has decreased from 56.05M to 48.05M, a decrease of -14.29%. That is a compound annual growth rate of -17.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 48.05M | 50.00% |
| Dec 31, 2025 | 32.03M | -42.86% |
| Oct 14, 2025 | 56.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prescient Therapeutics | 89.38M |
| LTR Pharma | 84.53M |
| Avecho Biotechnology | 72.78M |
| Arovella Therapeutics | 72.53M |
| Immutep | 67.79M |
| Amplia Therapeutics | 66.73M |
| Entropy Neurodynamics | 57.11M |
| Radiopharm Theranostics | 55.00M |